NCT01161667View on ClinicalTrials.gov

Bioequivalency Study of Naratriptan Hydrochloride 2.5 mg Under Fasted Conditions

NACompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

September 30, 2007

Study Completion Date

September 30, 2007

Conditions
Migraine
Interventions
DRUG

naratriptan hydrochloride

2.5 mg tablet

Trial Locations (1)

98418

Charles River Northwest Kinetics, Tacoma

All Listed Sponsors
lead

Roxane Laboratories

INDUSTRY

NCT01161667 - Bioequivalency Study of Naratriptan Hydrochloride 2.5 mg Under Fasted Conditions | Biotech Hunter | Biotech Hunter